CLX vs ELF vs REYN
161 measures in 16 categories, one definition each, computed from filings and market data.
CLX40.0
The Clorox Company
Consumer Defensive · Household & Personal Products
$87.09 +1.03%$10.5B mkt cap
Score DNA
ELF59.9
e.l.f. Beauty, Inc.
Consumer Defensive · Household & Personal Products
$113.54 −2.22%$6.7B mkt cap
Score DNA
REYN55.2
Reynolds Consumer Products Inc.
Consumer Defensive · Household & Personal Products
$22.82 +0.71%$4.8B mkt cap
Score DNA
Price, rebased to 100 three years ago
CLX ELF REYN · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| Insider open-market buys, 180d | 1 | 0 | 0 |
| Insider $ bought, 180d | $0.43M | — | — |
| Congress purchases, 180d | 0 | 0 | 0 |
| Last Congress purchase | — | — | — |
| 13F net change in holders | −36 | — | +28 |
| ETFs adding shares, 30d | 602 | 258 | 192 |
| ETFs trimming, 30d | 483 | 167 | 172 |
| Net ETF funds, 30d | +119 | +91 | +20 |
Valuation
16 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| P/E (TTM) | 17.9x
9th
|
112.4x
91st
|
13.9x
0th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 0.30
0th
|
— | 1.07
29th
|
| Price / sales | 1.6x
37th
|
3.8x
89th
|
1.3x
32nd
|
| Price / book | 117.0x
95th
|
5.7x
74th
|
2.1x
32nd
|
| Price / tangible book | — | — | — |
| Price / free cash flow | 26.0x
94th
|
23.9x
81st
|
15.0x
44th
|
| Price / operating cash flow | 17.2x
75th
|
22.6x
100th
|
9.6x
38th
|
| Enterprise value | $15.9B
68th
|
$7.3B
58th
|
$6.4B
53rd
|
| EV / sales | 2.4x
53rd
|
4.1x
89th
|
1.7x
42nd
|
| EV / EBITDA | 13.6x
31st
|
32.8x
88th
|
10.2x
12th
|
| EV / EBIT | 17.3x
36th
|
56.1x
93rd
|
13.0x
7th
|
| EV / free cash flow | 39.3x
88th
|
26.0x
75th
|
20.0x
44th
|
| Earnings yield | 5.6%
95th
|
0.9%
47th
|
7.2%
100th
|
| FCF yield | 3.8%
21st
|
4.2%
32nd
|
6.7%
63rd
|
| Operating cash flow yield | 5.8%
37th
|
4.4%
16th
|
10.5%
68th
|
| Graham number (per share) | $8.93
18th
|
$20.96
55th
|
$19.98
45th
|
Profitability (TTM)
12 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| Gross margin | 42.3%
37th
|
74.4%
95th
|
25.1%
5th
|
| EBITDA margin | 17.4%
68th
|
12.6%
58th
|
16.6%
63rd
|
| Operating margin | 24.7%
100th
|
10.5%
53rd
|
14.1%
68th
|
| EBIT margin | 13.7%
68th
|
7.4%
53rd
|
13.0%
63rd
|
| Net margin | 8.7%
63rd
|
3.4%
58th
|
9.1%
68th
|
| NOPAT margin | 18.8%
100th
|
7.5%
53rd
|
10.9%
68th
|
| FCF margin | 6.0%
37th
|
15.9%
79th
|
8.5%
47th
|
| Operating cash flow margin | 9.1%
32nd
|
16.9%
74th
|
13.3%
58th
|
| R&D / revenue | 1.7%
79th
|
0.0%
0th
|
0.0%
0th
|
| SG&A / revenue | 15.9%
11th
|
63.0%
79th
|
10.5%
5th
|
| Stock comp / revenue | 0.7%
39th
|
5.5%
100th
|
0.4%
17th
|
| Effective tax rate | 24.0%
68th
|
28.7%
84th
|
23.0%
58th
|
Returns on capital
11 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| ROE (on average equity) | 285.6%
95th
|
6.0%
58th
|
15.5%
63rd
|
| ROA | 8.8%
79th
|
3.2%
58th
|
6.9%
68th
|
| ROIC | 23.1%
79th
|
7.5%
42nd
|
10.6%
53rd
|
| ROCE | 18.3%
79th
|
6.1%
47th
|
11.1%
63rd
|
| Return on tangible assets | 13.8%
79th
|
6.9%
58th
|
9.9%
68th
|
| Cash ROIC (OCF / invested capital) | 11.2%
29th
|
17.0%
59th
|
12.9%
41st
|
| Gross profitability (GP / assets) | 36.5%
53rd
|
53.3%
68th
|
18.7%
5th
|
| ROIC, 3-yr average | 16.5%
76th
|
11.2%
65th
|
7.8%
53rd
|
| ROIC, 5-yr average | 15.1%
71st
|
20.0%
79th
|
8.1%
50th
|
| ROE, 5-yr average | 228.1%
100th
|
12.8%
56th
|
15.1%
62nd
|
| Incremental ROIC | 26.9%
79th
|
6.4%
68th
|
235.2%
100th
|
Growth
17 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| Revenue growth (TTM YoY) | -5.4%
21st
|
31.2%
89th
|
2.7%
58th
|
| Revenue growth (QoQ) | 16.6%
84th
|
6.7%
58th
|
7.6%
63rd
|
| Revenue CAGR, 3 yr | -3.1%
22nd
|
37.9%
94th
|
-0.7%
33rd
|
| Revenue CAGR, 5 yr | -1.8%
27th
|
38.1%
100th
|
2.5%
47th
|
| Gross profit CAGR, 3 yr | -0.7%
17th
|
41.8%
94th
|
5.6%
50th
|
| Operating income CAGR, 3 yr | 24.7%
92nd
|
19.9%
83rd
|
8.3%
67th
|
| Net income growth (TTM YoY) | -27.5%
30th
|
-39.1%
10th
|
10.9%
80th
|
| Net income CAGR, 3 yr | 57.9%
100th
|
-15.9%
20th
|
13.3%
70th
|
| EPS growth (TTM YoY) | -26.6%
30th
|
-41.2%
10th
|
10.1%
70th
|
| EPS CAGR, 3 yr | 59.0%
100th
|
-17.1%
20th
|
13.0%
70th
|
| EPS CAGR, 5 yr | -3.2%
33rd
|
32.6%
100th
|
-2.0%
44th
|
| FCF growth (TTM YoY) | -46.8%
0th
|
107.6%
92nd
|
6.0%
8th
|
| FCF CAGR, 3 yr | -24.2%
15th
|
44.7%
85th
|
16.6%
62nd
|
| Operating cash flow CAGR, 3 yr | -19.1%
7th
|
46.4%
100th
|
15.7%
71st
|
| Book value CAGR, 3 yr | -25.3%
12th
|
33.4%
88th
|
7.2%
71st
|
| Dividend CAGR, 3 yr | 0.7%
33rd
|
— | -0.3%
25th
|
| Sustainable growth rate | -7.3%
9th
|
6.0%
36th
|
6.9%
45th
|
Margin history & stability
7 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| Gross margin, 3-yr average | 43.4%
37th
|
72.0%
95th
|
26.0%
5th
|
| Operating margin, 3-yr average | 18.2%
89th
|
11.5%
58th
|
14.5%
63rd
|
| Net margin, 3-yr average | 8.0%
58th
|
7.2%
53rd
|
9.1%
63rd
|
| FCF margin, 3-yr average | 7.8%
58th
|
9.8%
68th
|
10.2%
74th
|
| Revenue stability (0-1) | 0.72
53rd
|
0.97
100th
|
0.45
26th
|
| Earnings stability (0-1) | 0.01
11th
|
0.32
42nd
|
0.00
0th
|
| Margin stability (0-1) | 0.95
42nd
|
0.95
37th
|
0.89
21st
|
Liquidity (latest quarter)
7 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| Cash & short-term investments | $143.0M
26th
|
$344.2M
68th
|
$66.0M
5th
|
| Net cash (− = net debt) | −$5.4B
26th
|
−$577.4M
68th
|
−$1.6B
53rd
|
| Working capital | −$949.0M
5th
|
$522.2M
74th
|
$525.0M
79th
|
| Current ratio | 0.66
0th
|
2.55
74th
|
1.80
53rd
|
| Quick ratio | 0.38
0th
|
1.82
74th
|
0.71
37th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.05
5th
|
1.02
79th
|
0.10
21st
|
| Defensive interval (days) | 288 days
68th
|
168 days
16th
|
386 days
84th
|
Leverage & solvency (latest quarter)
13 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| Total debt | $5.5B
68th
|
$921.7M
37th
|
$1.6B
47th
|
| Debt / equity | 61.33
100th
|
0.79
42nd
|
0.71
37th
|
| Net debt / equity | 59.74
100th
|
0.49
32nd
|
0.68
47th
|
| Debt / assets | 70.8%
100th
|
37.5%
68th
|
32.4%
42nd
|
| Debt / capital | 98.4%
100th
|
44.1%
42nd
|
41.6%
37th
|
| Debt / EBITDA | 4.73
56th
|
4.15
50th
|
2.63
38th
|
| Net debt / EBITDA | 4.60
62nd
|
2.60
50th
|
2.52
44th
|
| Interest coverage (EBIT / interest) | 7.1x
61st
|
2.8x
50th
|
11.2x
78th
|
| Cash interest coverage | 4.7x
39th
|
6.5x
56th
|
11.4x
67th
|
| Debt payback (years of OCF) | 9.0 yrs
81st
|
3.1 yrs
44th
|
3.3 yrs
50th
|
| Liabilities / assets | 96.8%
100th
|
52.5%
32nd
|
54.5%
37th
|
| IS credit model rating | BB | BBB+ | A- |
| Implied credit spread (bps) | 475
58th
|
225
37th
|
175
32nd
|
Efficiency
11 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| Asset turnover | 1.01
89th
|
0.93
74th
|
0.76
42nd
|
| Fixed asset turnover | 3.51
22nd
|
44.39
89th
|
3.92
28th
|
| Inventory turnover | 6.0
89th
|
2.2
21st
|
4.2
63rd
|
| Receivables turnover | 8.4
37th
|
10.1
53rd
|
11.0
63rd
|
| Days sales outstanding | 43 days
63rd
|
36 days
47th
|
33 days
37th
|
| Days inventory outstanding | 61 days
11th
|
169 days
79th
|
87 days
37th
|
| Days payables outstanding | 115 days
68th
|
69 days
37th
|
53 days
21st
|
| Cash conversion cycle (days) | −10 days
16th
|
136 days
89th
|
67 days
53rd
|
| Capex / revenue | 3.1%
71st
|
1.0%
6th
|
4.8%
94th
|
| Capex / depreciation | 0.84
71st
|
0.18
0th
|
1.36
94th
|
| Operating expense ratio | — | 61.8%
78th
|
11.3%
6th
|
Cash flow & earnings quality
7 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| Operating cash flow / net income | 1.04
9th
|
4.98
91st
|
1.46
36th
|
| FCF / net income | 0.69
9th
|
4.70
91st
|
0.93
18th
|
| FCF / operating cash flow | 66.2%
31st
|
94.3%
94th
|
63.6%
12th
|
| Capex / operating cash flow | 33.8%
69th
|
5.7%
6th
|
36.4%
88th
|
| Accruals ratio | -0.4%
95th
|
-12.6%
11th
|
-3.2%
84th
|
| Sloan accruals ratio | -13.3%
5th
|
0.6%
79th
|
-2.0%
53rd
|
| Earnings quality score (0-1) | 1.00
73rd
|
0.75
9th
|
1.00
73rd
|
Scores & forensic checks
15 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| IS score | 40
42nd
|
60
74th
|
55
63rd
|
| IS profitability | 68
89th
|
52
63rd
|
43
58th
|
| IS growth | 41
26th
|
41
32nd
|
49
58th
|
| IS value | 49
63rd
|
36
16th
|
59
89th
|
| IS momentum | 45
21st
|
70
58th
|
78
84th
|
| IS risk (safety) | 50
32nd
|
80
63rd
|
65
47th
|
| IS quality | 50
42nd
|
69
68th
|
73
79th
|
| IS balance sheet | 25
21st
|
59
79th
|
58
74th
|
| IS earnings quality | 82
89th
|
65
47th
|
84
95th
|
| IS cash flow | 34
21st
|
75
95th
|
55
47th
|
| Piotroski F-score (0-9) | 4
5th
|
4
5th
|
7
63rd
|
| Altman Z-score | 2.1
32nd
|
3.1
63rd
|
2.7
47th
|
| Beneish M-score | −2.01
95th
|
−2.70
74th
|
−2.60
84th
|
| Ohlson O-score | −4.71
89th
|
−7.58
37th
|
−7.75
32nd
|
| IS credit score | 41
32nd
|
62
58th
|
65
68th
|
Size (TTM)
8 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| Market cap | $10.5B
68th
|
$6.7B
63rd
|
$4.8B
58th
|
| Revenue | $6.7B
68th
|
$1.8B
26th
|
$3.8B
53rd
|
| EBITDA | $1.2B
68th
|
$221.9M
37th
|
$627.0M
63rd
|
| Net income | $587.0M
74th
|
$59.6M
47th
|
$345.0M
68th
|
| Free cash flow | $405.0M
68th
|
$280.2M
47th
|
$320.0M
58th
|
| Total assets | $7.8B
58th
|
$2.5B
32nd
|
$5.1B
53rd
|
| Shareholders' equity | $90.0M
0th
|
$1.2B
47th
|
$2.3B
68th
|
| Employees | 9,200
63rd
|
849
26th
|
6,000
47th
|
Price performance
9 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| 1 day | +1.0% | −2.2% | +0.7% |
| 1 week | +3.9% | +3.9% | +3.7% |
| 1 month | +2.5% | +21.7% | +0.6% |
| 3 months | −8.5% | +42.5% | −12.4% |
| 6 months | −14.7% | +69.9% | +2.1% |
| Year to date | −10.6% | +45.9% | −0.0% |
| 1 year | −23.0% | −15.3% | −3.1% |
| 3 years, cumulative | −20.1% | +8.0% | −2.1% |
| 5 years, cumulative | −36.5% | +283.0% | −4.2% |
Technicals
4 measures| Measure | CLX | ELF | REYN |
|---|---|---|---|
| RSI 14 | 53.5 | 66.5 | 57.2 |
| From 52-week high | −30.8% | −19.8% | −16.5% |
| From 52-week low | +10.1% | +132.6% | +12.3% |
| Beta | 0.57 | 2.39 | 0.54 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17